NYSE · Shell Companies · USD

Bain Capital GSS Investment Corp. (BCSS) Stock Analysis

Bain Capital GSS Investment Corp. (BCSS) is a Shell Companies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

BCSS

$10.21

−$0.01 (−0.05%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BCSS with… →

BCSS Key Statistics

As of Oct 21, 2026

Trading

Open: $10.21
Previous Close: $10.21
Day's Range: 10.21–10.21
52-Week Range: 9.95–10.48
Volume: 2.68K

Valuation

Market Cap: $596.26M

Financials (FY)

Shares Outstanding: 46.90M

Dividend and dates

Avg Volume: 65.23K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Bain Capital GSS Investment Corp. (BCSS) has a market capitalization of $596.26M.

BCSS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+1.24%
2025 (partial year)	+0.00%

As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values Bain Capital GSS Investment Corp. (BCSS) at $596.26M. The company sits in the Financial Services sector, in the Shell Companies industry.

BCSS last closed at $10.21 on October 21, 2026. That is −$0.01 (−0.05%) against the previous close. Over the past 52 weeks the price has ranged from $9.95 to $10.48. The latest close sits 2.56% above that 52-week low.

Valuation Assessment

The stored price history starts on November 20, 2025, and the total return since then is +1.24%.

Growth & Income

No dividend is on file for BCSS.

2026 is still running; the total return is +1.24% year to date.

Peer Comparison

Bain Capital GSS Investment Corp. (BCSS) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Bain Capital GSS Investment Corp.	BCSS	$596.26M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Bain Capital GSS Investment Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

CXII

Churchill Capital Corp XII

$577.16M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Bain Capital GSS Investment Corp.

Bain Capital GSS Investment Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was incorporated in 2025 and is based in Boston, Massachusetts.

Visit website →